Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Other Non-Current Assets (2016 - 2025)

Lifecore Biomedical, Inc. \De\ (LFCR) has 15 years of Other Non-Current Assets data on record, last reported at $6.6 million in Q2 2025.

  • For Q2 2025, Other Non-Current Assets rose 15.79% year-over-year to $6.6 million; the TTM value through May 2025 reached $6.6 million, up 15.79%, while the annual FY2025 figure was $6.6 million, 15.79% up from the prior year.
  • Other Non-Current Assets reached $6.6 million in Q2 2025 per LFCR's latest filing, up from $4.9 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $133.2 million in Q4 2021 and bottomed at $2.6 million in Q4 2024.
  • Average Other Non-Current Assets over 5 years is $15.2 million, with a median of $4.1 million recorded in 2023.
  • Peak YoY movement for Other Non-Current Assets: skyrocketed 9901.13% in 2021, then tumbled 98.04% in 2022.
  • A 5-year view of Other Non-Current Assets shows it stood at $133.2 million in 2021, then crashed by 98.04% to $2.6 million in 2022, then surged by 56.31% to $4.1 million in 2023, then tumbled by 36.96% to $2.6 million in 2024, then skyrocketed by 156.25% to $6.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Non-Current Assets were $6.6 million in Q2 2025, $4.9 million in Q1 2025, and $2.6 million in Q4 2024.